UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039674
Receipt number R000045253
Scientific Title Effects of a test food on skin conditons
Date of disclosure of the study information 2020/03/03
Last modified on 2020/07/09 09:45:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of a test food on skin conditons

Acronym

Effects of a test food on skin conditons

Scientific Title

Effects of a test food on skin conditons

Scientific Title:Acronym

Effects of a test food on skin conditons

Region

Japan


Condition

Condition

N/A(healthy adults)

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to examine effects of a test food for skin conditions.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Indexes for skin conditions (0, 24 days after ingestion)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Oral ingestion of the test food for 24 days

Interventions/Control_2

Oral ingestion of the placebo food for 24 days

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

70 years-old >

Gender

Female

Key inclusion criteria

1)Japanese individuals aged 30-69 years.
2)Individuals who are not suffered from a chronic malady including skin disease.
3)Individuals who are anxious about skin dryness.
4)Individuals whose written informed consent has been obtained.
5)Individulals who can visit an inspection facility and be inspected in designated days.
6)Individuals judged appropriate for the study by the principal.

Key exclusion criteria

1)Individuals using medical products.
2)Individuals with skin disease symptoms such as atopic dermatitis.
3)Individuals with strange skin conditions at measurement points.
4)Individuals who used or applied a drug for treatment of disease in the past 1 month.
5)Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung and blood disease.
6)Individuals who contract or have a history of serious gastrointestinal disease.
7)Individuals with serious anemia.
8)Individuals with food allergy.
9)Females who are or are possibly pregnant, or are lactating.
10)Individuals who have an addiction to alcohol or a mental illness.
11)Individuals who are a smoker.
12)Individuals whose life style will change during the test period.
13)Individuals with probable seasonal allergy, such as pollinosis, during the test period.
14)Individuals who will get sunburned during the test period.
15)Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements that have the function of maintaining and improving skin moisture in the past 3 months or will ingest those foods during the test period.
16)Individuals who have a habit to use drug claiming to improve skin condition in the past 3 months.
17)Individuals who conducted hormone replacement therapy in the past 6 months or have a history of conducting hormone replacement therapy.
18)Individuals who have received a cosmetic medicine in the past 6 months.
19)Individuals who were hospitalized and received treatment in the past 6 months.
20)Individuals who participated in other clinical studies in the past 3 months.
21)Individuals judged inappropriate for the study by the principal.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Minoru
Middle name
Last name Morita

Organization

Morinaga & Co., Ltd.

Division name

Health Science and Research Center, R&D institute

Zip code

230-8504

Address

2-1-1, Shimosueyoshi, Tsurumi-ku, Yokohama

TEL

045-571-6140

Email

m-morita-je@morinaga.co.jp


Public contact

Name of contact person

1st name Sadao
Middle name
Last name Mori

Organization

MORINAGA & CO., LTD.

Division name

Health Science and Research Center, R&D institute

Zip code

230-8504

Address

2-1-1, Shimosueyoshi, Tsurumi-ku, Yokohama

TEL

045-571-6140

Homepage URL


Email

s-mori-ab@morinaga.co.jp


Sponsor or person

Institute

MORINAGA & CO., LTD.

Institute

Department

Personal name



Funding Source

Organization

Morinaga & Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Non-Profit Organization MINS Institutional Review Board

Address

5-20-9-401,Mita,Minato-ku,Tokyo,Japan

Tel

03-6416-1868

Email

npo-mins@j-irb.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2020 Year 02 Month 20 Day

Date of IRB

2020 Year 02 Month 20 Day

Anticipated trial start date

2020 Year 03 Month 03 Day

Last follow-up date

2020 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 03 Month 03 Day

Last modified on

2020 Year 07 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045253


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name